Autologous Platelet-Derived Growth Factors (Platelet-Rich Plasma [PRP]) - (0507) — MM 0507 | CIGNA Coverage Update

Cigna modified MM 0507 for platelet-rich plasma (PRP), effective October 16, 2025. Both CPT 0232T and HCPCS G0460 are classified as experimental — and that's the entire coverage story here.

If your team bills PRP injections for any indication under Cigna Healthcare, this update matters. The Cigna PRP coverage policy under MM 0507 Cigna system draws a hard line: there are no covered indications. Every proposed use of autologous platelet-derived growth factors (APDGF) — whether for orthopedic injuries, wound care, or anything else — falls under the experimental/investigational/unproven designation. For billing teams, that means claim denial is not a risk. It's a near-certainty if you submit without understanding this policy.

Quick-Reference Table

Field	Detail
Payer	Cigna Healthcare
Policy	Autologous Platelet-Derived Growth Factors (Platelet-Rich Plasma [PRP])
Policy Code	MM 0507
Change Type	Modified
Effective Date	October 16, 2025
Impact Level	High
Specialties Affected	Orthopedics, wound care, dermatology, sports medicine, podiatry, pain management
Key Action	Stop submitting CPT 0232T and HCPCS G0460 to Cigna without a confirmed financial responsibility agreement — these codes are non-covered under all current indications

Cigna Platelet-Rich Plasma Coverage Criteria and Medical Necessity Requirements 2025

Here's the short version: Cigna Healthcare does not cover PRP for any indication under MM 0507. There are no medical necessity criteria to meet, because no use of autologous platelet-derived growth factors currently clears Cigna's clinical evidence bar.

This is not a narrow exclusion. The coverage policy applies to all proposed uses of APDGF/PRP — across every site of injection, every diagnosis, every specialty. If you're wondering whether PRP coverage under Cigna applies to your specific patient population, the answer is no.

The two codes in scope are CPT 0232T (injection of platelet-rich plasma, any site, including image guidance, harvesting, and preparation) and HCPCS G0460 (autologous PRP or other blood-derived product for nondiabetic chronic wounds). Both land in the same bucket: experimental, investigational, and unproven.

Prior authorization won't save you here. When a payer classifies a service as experimental, prior authorization isn't a pathway to reimbursement — it's a non-starter. There is no prior auth process that unlocks coverage for a service Cigna has categorized this way. If a patient asks whether Cigna will cover their PRP injection, your front desk needs a clear answer before the appointment, not after.

The medical necessity standard Cigna applies to PRP is straightforward: the clinical evidence doesn't support it as a proven treatment. Until that changes — and Cigna revises this coverage policy — billing these codes to Cigna is billing for a non-covered service.

Cigna PRP Exclusions and Non-Covered Indications

Every indication under this policy is non-covered. That's worth saying plainly because some providers assume that wound care applications (via HCPCS G0460) might be treated differently from orthopedic injections (CPT 0232T). They're not.

HCPCS G0460 specifically covers autologous PRP for nondiabetic chronic wounds. You might expect wound care to have a different evidence profile than, say, tennis elbow or knee osteoarthritis. Cigna's position is that the evidence doesn't support coverage in either category — or any other.

CPT 0232T is equally broad. The code covers injections at any site, with or without image guidance. That scope — "any site" — means Cigna's non-coverage applies whether the injection is into a joint, a tendon, a wound bed, or anywhere else.

The real issue here is that providers sometimes assume this classification is outdated or inconsistently applied. It isn't. Cigna has maintained the experimental designation for PRP across multiple policy reviews. This October 16, 2025 modification is a continuation of that position, not an opening.

Coverage Indications at a Glance

Indication	Status	Relevant Codes	Notes
PRP injection, any site (orthopedic, musculoskeletal, or other)	Experimental / Not Covered	CPT 0232T	Includes image guidance, harvesting, and preparation — all components non-covered
Autologous PRP for nondiabetic chronic wounds	Experimental / Not Covered	HCPCS G0460	Applies regardless of wound type or stage
All other proposed APDGF/PRP indications	Experimental / Not Covered	CPT 0232T, HCPCS G0460	No covered indications exist under MM 0507

Cigna Platelet-Rich Plasma Billing Guidelines and Action Items 2025

The effective date is October 16, 2025. These steps apply now.

#	Action Item
1	Pull your Cigna claim history for CPT 0232T and HCPCS G0460. Look at the last 12 months. If you've been submitting these codes and getting paid, something is off — either the claims slipped through or they were billed under a different payer or plan type. Identify the volume now.
2	Update your charge capture and billing guidelines to flag both codes. Mark CPT 0232T and HCPCS G0460 as non-covered under Cigna Healthcare plans. Your billing system should block or warn before these codes hit a Cigna claim.
3	Build a patient financial responsibility workflow for PRP patients. If you're offering PRP services and a patient has Cigna coverage, they need a written financial responsibility agreement before the procedure. This isn't optional — it protects you from claim denial disputes and sets correct expectations up front.
4	Do not submit a prior authorization request as a workaround. Experimental/investigational designations don't have a prior auth pathway at Cigna. A PA request for CPT 0232T or G0460 will not result in approval. It wastes time and creates a paper trail that complicates any later billing inquiry.
5	Audit any bundled or upcoded claims involving PRP. Some providers include PRP preparation or administration under other procedure codes. If your documentation references platelet-rich plasma and those claims go to Cigna, they're exposed — even if the code on the claim isn't 0232T or G0460. Review your documentation standards now.
6	Talk to your compliance officer if you operate across multiple states or plan types. Cigna's fully insured plans follow MM 0507 directly. Self-funded plans may or may not adopt this coverage policy. Your compliance officer or billing consultant should verify plan-level coverage before you assume the same rules apply across your entire Cigna patient panel.

+ 3 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

CPT and HCPCS Codes for Platelet-Rich Plasma Under MM 0507

The policy data for MM 0507 includes two codes. Both are classified as experimental/investigational/unproven. There are no covered CPT or HCPCS codes under this policy, and no ICD-10 diagnosis codes are listed in the policy data.

Experimental / Non-Covered Codes

Code	Type	Description	Classification
0232T	CPT	Injection(s), platelet rich plasma, any site, including image guidance, harvesting and preparation	Experimental / Investigational / Unproven
G0460	HCPCS	Autologous platelet rich plasma (PRP) or other blood-derived product for nondiabetic chronic wounds	Experimental / Investigational / Unproven

A note on CPT 0232T: this is a Category III CPT code, which signals emerging technology with limited published evidence. Cigna's classification aligns with how most major payers currently treat Category III codes — they carry no assumed coverage until clinical evidence reaches a defined threshold.

HCPCS G0460 has a Medicare history that sometimes creates confusion. CMS has addressed PRP for chronic wounds through specific local coverage determinations (LCDs) in certain jurisdictions, and some Medicare Administrative Contractors have issued coverage for limited wound care applications. That Medicare history does not transfer to Cigna. MM 0507 Cigna system applies its own evidence review, and the result is non-coverage. If your patient has Medicare as primary and Cigna as secondary, the crossover rules still won't generate Cigna reimbursement for a non-covered service.

No ICD-10-CM codes appear in the MM 0507 policy data. This is consistent with a blanket non-coverage position — when there are no covered indications, there are no relevant diagnosis codes to list.